Sailong Pharmaceutical Group Co.,Ltd. (China)

Sailong Pharmaceutical Group Co., Ltd. (referred to as "Sailong Pharmaceutical") was established in 2002. It is a high-tech enterprise that integrates pharmaceutical research and development, production, and sales. The company's main products are focused on the fields of the nervous system, cardiovascular system, and digestive system. Since its establishment, Sailong Pharmaceutical has been committed to providing "safe and efficient" drugs to society. The company has emphasized technological innovation and new drug development. Its research and development center, located in the state-of-the-art Sailong Building, is equipped with a range of precision instruments recommended by the US FDA and recognized by international drug research institutions. The center has gathered a group of knowledgeable and dedicated scientists, led by doctors and supported by masters, who have gradually established research platforms in the areas of chiral drugs, controlled-release drugs, and biochemical drugs. Sailong Pharmaceutical has obtained 11 drug approvals, multiple drug invention patents, and clinical approvals for drugs such as "Levofloxacin Sodium" and more than ten supplementary research approvals, establishing its characteristics and advantages in the fields of cardiovascular, nervous system, new antibiotics, and digestive system drug development. Sailong Pharmaceutical recognizes that drugs are special commodities that treat and save lives. The company continuously pursues excellence in the quality of its products. It implements real-time monitoring of production environment cleanliness throughout the entire process and multi-point endotoxin monitoring of intermediate products, reflecting the craftsmanship spirit of excellence. Currently, the company has established advanced facilities for the production of modern lyophilized powder injections, small-volume injections, biochemical raw materials, and chemical synthesis raw materials. It possesses a complete set of modern production and inspection equipment, has repeatedly passed GMP certification for all production lines at high standards, and has been recognized as a high-tech enterprise. Its products are sold in 30 provinces, cities, and autonomous regions. Looking to the future, Sailong Pharmaceutical will continue to uphold the principle of "leading with technology, achieving a healthy cause" and practice the corporate culture of "unity, hard work, dedication, and contribution." The company aims to dedicate its outstanding scientific research achievements and efficient and high-quality health products to the cause of human health.